Therma Bright Inc (CVE:THRM) (OTCMKTS:TBRIF) Stock In Focus After Recent Developments

February 17, 2022

At this point in time, Therma Bright Inc (CVE:THRM) (OTCMKTS:TBRIF) is best known for having developed the AcuVid™ COVID-19 Rapid Antigen Saliva Test. However, it is perhaps also important for investors to keep in mind that the company is also involved in the development of other forms of medical devices as well as technologies for the diagnostics space. AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration’s…

Read More >>

Therma Bright Inc (OTCMKTS:TBRIF) (TSXV: THRM) Stock In Focus After Latest Developments

February 8, 2022

Investors are often prone to look into stocks which may have clocked notable gains over a sustained period of time before considering looking into it. Gains made over a period of one week is often seen as a good barometer and by that token, it may be the right time to perhaps start tracking the Therma Bright Inc (OTCMKTS:TBRIF) (TSXV: THRM) stock. In the past week, the stock has managed…

Read More >>